Quantitative phosphoproteomic profiling of CCL5/CCR5 signaling cascade in melanoma cells - Report - MDSpire

Quantitative phosphoproteomic profiling of CCL5/CCR5 signaling cascade in melanoma cells

  • By

  • Xie, Lifen

  • Zhu, Tianhui

  • He, An

  • Wu, Qin

  • Zeng, Jinfeng

  • Huang, Liqin

  • Zhang, Ling

  • Liu, Jie

  • June 22, 2026

  • 0 min

Share

Dynamic Phosphoproteomic Analysis of CCL5/CCR5 Signaling in Melanoma Cells

Overview

This study investigates the dynamic phosphorylation events in melanoma cells following CCL5 stimulation, revealing significant modulation of phosphosites and proteins involved in cell cycle regulation.

Background

The CCL5/CCR5 signaling pathway is crucial in tumor progression and metastasis, particularly in melanoma. Understanding the downstream effects of CCR5 activation can provide insights into the molecular mechanisms driving these processes.

Data Highlights

Time Point (min)Number of Modulated Phosphosites
5256
10134
3083

Key Findings

  • 393 phosphosites across 315 phosphoproteins were significantly regulated following CCL5 stimulation.
  • 52 phosphoproteins were identified as CCR5-mediated, with distinct temporal dynamics.
  • Gene Ontology analysis indicated involvement in various biological processes, especially cell cycle regulation.
  • Phosphorylation activation of CEP131, KHDRBS1, and MAPK6 was observed upon CCL5 stimulation, which was inhibited by CCR5 knockout.
  • The study provides a comprehensive phosphorylation resource for understanding CCL5/CCR5-related tumor progression.

Clinical Implications

The findings suggest that targeting the CCL5/CCR5 signaling pathway may offer new therapeutic strategies in melanoma treatment. Understanding the phosphorylation dynamics could aid in the development of targeted therapies.

Conclusion

This research enhances the understanding of CCL5/CCR5 signaling in melanoma and identifies potential molecular targets for therapeutic intervention.

Related Resources & Content

  1. Blood Cancer Journal, 2025 -- Macrophages Expressing PDL1 Infiltrate Diffuse Large B-Cell Lymphoma and Enhance Tumor Growth in a MYC-Driven Experimental Model
  2. Blood Cancer Journal, 2011 -- Regulation of CXCR4 Expression in Acute Myeloid Leukemia by MicroRNA-146a and AMD3100
  3. Blood Cancer Journal, 2023 -- Targeting PRMT5 for Combination Treatment in Mantle Cell Lymphoma with Frequent ATM and TP53 Mutations
  4. Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - ScienceDirect
  5. Journal of Clinical Oncology -- Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase 2b KEYNOTE-942 Study
  6. C–C motif glycoprotein ligand 5 (CCL5) and its GPCR CCR5: Macromolecular game-changers in cancer biology - ScienceDirect
  7. Blood Cancer Journal — The Role of the DLEU2/miR-15a/miR-16-1 Cluster in Modulating the Immune Environment in Chronic Lymphocytic Leukemia
  8. Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - ScienceDirect
  9. Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase 2b KEYNOTE-942 Study | Journal of Clinical Oncology
  10. C–C motif glycoprotein ligand 5 (CCL5) and its GPCR CCR5: Macromolecular game-changers in cancer biology - ScienceDirect

Original Source(s)

Related Content